Funder
Janssen Pharmaceuticals
Food and Health Bureau
Roche
Gilead Sciences
Health and Medical Research Fund
Reference94 articles.
1. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013;Schweitzer;Lancet,2015
2. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study;Lancet Gastroenterol Hepatol,2018
3. World Health Organization. Global health sector strategy on viral hepatitis 2016–2021. Website: https://www.who.int/hepatitis/strategy2016-2021/ghss-hep/en/. Accessed on 20 April 2021.
4. Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference;Cornberg;J Hepatol,2019
5. HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos(t)ide analogues;Yip;J Hepatol,2019
Cited by
62 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献